Clinical trial
Assess Cancer in Ovarian Tumors With Biomarkers.
NCT00436189 · Ciphergen Biosystems, Industry · Completed
Key facts
| NCT number | NCT00436189 |
|---|---|
| Title | Assess Cancer in Ovarian Tumors With Biomarkers. |
| Official title | Whole Blood Collection Protocol For Ovarian Assay Clinical Trial In Women With Ovarian Tumors |
| Lead sponsor | Ciphergen Biosystems, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Ovarian Tumor |
| Intervention type | Procedure |
| Interventions | Blood Draw |
| Enrollment | 1,000 |
| Start date | Feb 1, 2007 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Feb 16, 2007 |
| Last update posted | Apr 30, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: